Mitomycin/hyaluronan complex

Drug Profile

Mitomycin/hyaluronan complex

Alternative Names: Hyaluronic acid/mitomycin complex; Mitomycin C + HA; Mitomycin-hyaluronic acid complex; Mitomycin/hyaluronic acid complex

Latest Information Update: 15 Aug 2002

Price : $50

At a glance

  • Originator Nonindustrial source; Shiseido
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer metastases

Most Recent Events

  • 23 Jul 1997 Mitomycin/hyaluronic acid complex is now called mitomycin/hyaluronan complex
  • 26 Sep 1996 Preclinical development for Cancer metastases in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top